PeptiDream Inc. (PPTDF) Research

PeptiDream Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative therapeutic solutions, including constrained peptides, small molecules, and peptide-drug conjugates. The company utilizes its exclusive Peptide Discovery Platform System (PDPS), an advanced drug discovery engine, to propel the development of its peptide-based product pipeline. PeptiDream also maintains a collaborative research initiative and an exclusive licensing agreement with Takeda Pharmaceutical Company Limited, specifically focused on developing peptide-drug conjugates for neuromuscular disorders. Founded in 2006, the company's operations are based in Kawasaki, Japan.

Market snapshot

Symbol
PPTDF
Price
$6.00
Day change
0.00%
Market cap
$123.3B
P/E ratio
-34.73x
52-week range
5.98-13.18
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Kuros Biosciences AG (CSBTF)
  • CStone Pharmaceuticals (CSPHF)
  • Genus plc (GENSF)
  • Mesoblast Limited (MEOBF)
  • Neuren Pharmaceuticals Limited (NURPF)
  • Oxford Nanopore Technologies plc (ONTTF)
  • Pharma Mar, S.A. (PHMMF)
  • Redcare Pharmacy N.V. (SAEYY)

Open PeptiDream Inc. (PPTDF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.